Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Dividends payables (2023)

Iradimed (IRMD) has disclosed Dividends payables for 1 consecutive years, with $8.0 million as the latest value for Q4 2023.

  • On a quarterly basis, Dividends payables changed N/A to $8.0 million in Q4 2023 year-over-year; TTM through Dec 2023 was $8.0 million, a N/A change, with the full-year FY2023 number at $8.0 million, changed N/A from a year prior.
  • Dividends payables was $8.0 million for Q4 2023 at Iradimed.
  • In the past five years, Dividends payables ranged from a high of $8.0 million in Q4 2023 to a low of $8.0 million in Q4 2023.